These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31173889)

  • 1. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017.
    Tickler IA; Obradovich AE; Goering RV; Fang FC; Tenover FC;
    Anaerobe; 2019 Dec; 60():102050. PubMed ID: 31173889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption.
    Seo MR; Kim B; Kim J; Pai H
    Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
    Piepenbrock E; Stelzer Y; Berger F; Jazmati N
    Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.
    Cheknis A; Johnson S; Chesnel L; Petrella L; Sambol S; Dale SE; Nary J; Sears P; Citron DM; Goldstein EJC; Gerding DN
    Anaerobe; 2018 Oct; 53():38-42. PubMed ID: 29886050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
    Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
    J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance for genotyping and resistance testing of Clostridium (Clostridioides) difficile isolates - Experiences from the first inter-laboratory ring trial in four German speaking countries.
    Berger FK; Mellmann A; von Müller L; Bischoff M; Gärtner BC;
    Anaerobe; 2020 Feb; 61():102093. PubMed ID: 31494260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
    Kim J; Kang JO; Pai H; Choi TY
    Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain.
    Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A
    Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological characteristics of human and animal isolates of Clostridioides difficile in Italy: Results of the Istituto Superiore di Sanità in the years 2006-2016.
    Barbanti F; Spigaglia P
    Anaerobe; 2020 Feb; 61():102136. PubMed ID: 31857201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
    Abdrabou AMM; Bischoff M; Mellmann A; von Müller L; Margardt L; Gärtner BC; Berger FK;
    Anaerobe; 2022 Oct; 77():102548. PubMed ID: 35307546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019.
    Abdrabou AMM; Ul Habib Bajwa Z; Halfmann A; Mellmann A; Nimmesgern A; Margardt L; Bischoff M; von Müller L; Gärtner B; Berger FK
    Int J Med Microbiol; 2021 May; 311(4):151507. PubMed ID: 33915347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015.
    Karlowsky JA; Adam HJ; Kosowan T; Baxter MR; Nichol KA; Laing NM; Golding G; Zhanel GG
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):105-111. PubMed ID: 29456070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterisation of Clostridium difficile PCR ribotype 251, an emerging multi-locus sequence type clade 2 strain in Australia.
    Hong S; Knight DR; Chang B; Carman RJ; Riley TV
    Anaerobe; 2019 Dec; 60():102066. PubMed ID: 31260740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.
    Tratulyte S; Miciuleviciene J; Kuisiene N
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
    Kato H; Senoh M; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102011. PubMed ID: 30872073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
    Freeman J; Vernon J; Morris K; Nicholson S; Todhunter S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.